|1.||Liu, Long-tao: 1 article (05/2011)|
|2.||Li, Hao: 1 article (05/2011)|
|3.||Han, Shu-hua: 1 article (05/2011)|
|4.||Zhou, Ru-Qian: 1 article (09/2007)|
|5.||Lin, Shui-Miao: 1 article (09/2007)|
|6.||Yuan, Quan: 1 article (09/2007)|
|1.||Alzheimer Disease (Alzheimer's Disease)
05/01/2011 - "(1) As to the conversion of MCI to Alzheimer's disease (AD), no case conversed to MCI in Jiawei Wuzi Yanzong Granule Group and Shenyin Oral Liquid Group. "
09/01/2007 - "To observe the therapeutic effect of Shenyin Oral Liquid (SOL) in relieving mild cognitive impairment (MCI) and decreasing the Alzheimer's disease (AD) transformation rate. "
|1.||Polymethyl Methacrylate (Sol)